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USA, 7-8 March 2002.
Over the past two decades, advances in genomic technology
have allowed laboratories to generate vast amounts of bio-
logical data. These data include, but are not limited to, gene
sequences, protein structures, information on gene expres-
sion (transcripts, metabolites and proteins) and metabolic
pathways. Automated instrumentation has enabled large
volumes of data to be generated and automatically stored in
computer databases, and this data has as many different
formats as there are instruments. In addition to the new
information gathered from genomic technologies, pharma-
ceutical and biotech companies have large amounts of
‘legacy data’ - data inherited from their own and other
sources on chemical structures and properties of com-
pounds, and clinical, phenotypic and toxicological informa-
tion. Most of this is stored in older types of databases
designed for the particular type of data, and a major compu-
tational challenge is to integrate the new genomic informa-
tion with current database systems in order to facilitate
decision-making.
Statistical approaches to data analysis and
experimental design
John Weinstein (National Cancer Institute (NCI), Bethesda,
USA) gave an overview of genomic and other ‘omic’ technolo-
gies and appropriately coined the new name ‘integromics’ for
the data-integration issues associated with genomic research.
He described a pharmaco-genomics database (Leadminer)
developed at NCI to support high-throughput chemical
screening using 60 cell lines and 70,000 chemical com-
pounds. He presented a variety of data-analysis techniques,
including the cluster-correlation image mapping (CIM) tech-
nique pioneered by his group in collaboration with that of
Mike Eisen (University of California at Berkeley, USA).
Cluster correlation provides a way of investigating gene-
expression patterns associated with drug activity, character-
izing both the cell lines and the putative modes of action of
the chemical compounds using hierarchical clustering
methods. He also presented results from the Medminer tool
[http://discover.nci.nih.gov], which streamlines searching
of the biomedical literature for annotation of genes used in
microarray experiments. Weinstein demonstrated the
success of his group at NCI in integrating the massive
dataset comprising results from microarrays, proteomics,
70,000 chemical compounds and 60 cell lines. 
Sherri Matis (Astra Zeneca Pharmaceuticals, Wilmington,
USA) described the data-integration challenges associated
with the analysis of expression-profiling data in molecular
toxicology. She described the application of principal com-
ponent analysis (PCA) for quality control, and the applica-
tion of naive Bayesian analysis for clustering, as a prelude to
identifying common promoter or enhancer elements. PCA, a
statistical algorithm, was used to identify characteristic pat-
terns of gene expression in the data, and to determine
whether these patterns were informative and could be used
to classify the samples into biologically appropriate groups.
Once it was determined that the expression data was of
acceptable quality, a Bayesian method of clustering was used
to identify groups of genes sharing similar expression pat-
terns. Once such a group was identified, the upstream regu-
latory regions were analyzed, using bioinformatics methods
to identify over-represented elements. She discussed how
clinical data, genomic and genetic information, motifs, and
pathways can be used along with expression profiling to add
additional annotation and prioritize genes in order of their
biological importance. She showed how ‘profiles’ of promot-
ers can be used in the analysis of tissue-specific, disease-spe-
cific or treatment-specific induction of gene expression.We (T.V.V. and H.B.H.) discussed the expression-profiling
process as it has been developed at Monsanto, as well as
giving a brief description of genomics computer applications
and an object-oriented bioinformatics framework (see
below). We find that classical experimental design strategies
can be used to integrate phenotypic, developmental and time-
course expression data in genomics-based experiments with
good results. 
Mike Liebman (Abramson Family Research Center, Philadel-
phia, USA) described a systems-engineering approach to
computational biology, focusing on the use of a combination
of mechanistic and statistical models to analyze clinical data
in oncology. He examined a variety of mechanistic models
associated with breast cancer, which take account of its
developmental progression and the existence of different
clinical types. If the a priori information on disease progres-
sion and classification can be accounted for using such
models, a significant amount of the clinical variation can be
explained. He presented a variant of the standard pedigree
model that included genealogy and an object-oriented data
model for medical history, which enables the integration and
analysis of a multidimensional set of clinical data, with the
aim of improving treatment strategy.
Software tools for gene-expression analysis
Jeffery Schaffer (Omniviz, Maynard, USA) presented tools
for analysis of free text, numerical data and genomic data.
Omniviz functional genomics tools include a relaxation clus-
tering method (Galaxy) for visualizing microarray data and
integrates text and genomic annotation data with the expres-
sion data. The suite of software presented by C. Brett Jesse
(Anvill Bioinformatics, Burlington, USA) for analyzing gene-
expression data uses traditional statistical tools for assessing
the quality of microarray data. Their proprietary visualiza-
tion tool ‘Radviz’ can display hundreds of data points, each
having thousands of attributes or descriptors. The software
uses several clustering methods to classify the data.
Database integration
Ramesh Durvasul (Tripos Inc, St. Louis, USA) described four
of the data-storage options currently available and their
advantages and disadvantages in regard to integration of dif-
ferent types of data. The first, and least favored for integra-
tion, is a single database, typically managed under a
relational database management system (where data col-
lected are stored and presented as a series of relations and
each relation is depicted in a table where columns are attrib-
utes and the rows represent entries). Although a relational
database enables efficient access to data by means of a struc-
tured query language (SQL), which can be used to retrieve
groups of data efficiently, it is cumbersome for data selection
and manipulation in a semantically rich domain like molecu-
lar biology. His second example was the ‘data warehouse’, in
which the core enterprise data (a collection of relational
databases representing all data ) are stored in a central store
and which connects to other relational databases from which
a subset of the data can be selectively extracted and loaded
for analysis. The data warehouse places an emphasis on the
ability to capture and copy data from a wide variety of
diverse sources. The third example, the ‘data mart’, stores
specialized data derived from a data warehouse for use in a
particular analysis. The emphasis here is on content, presen-
tation and ease of use in formats familiar to the specialized
users. In the fourth example, the ‘federated database’, many
databases are connected through a specialized network
service shared by applications (databases and tools) and
users, to create a virtual data warehouse. With good design,
data warehouses and data marts can perform well in storing
and retrieving biological data. But they have limited flexibil-
ity to accommodate to changing requirements and are
expensive to implement. Federated databases are more flexi-
ble and less expensive, but it is often difficult to optimize
their performance to deal with different types of data. 
Richard Scott (DeNovo Pharmaceuticals, Cambridge, UK)
discussed the advantages of a federated data warehouse
strategy to support older systems from different domains
and vendors. This approach allows new types of data to be
plugged into the system and data from third-party systems
to remain in their own application environments. A feder-
ated data warehouse allows users to use their own client
applications and to share each other’s data without learning
each other’s applications (for example, a biologist uses bio-
logical systems and a chemist uses chemical systems). The
virtual data warehouse was described as needing an indus-
trial-strength application server, a robust compute farm (a
large group of interconnected computers each performing
different parts of the same task), ample storage space, and a
sound relational database management system. Scott also
pointed out the advantages of employing open-source tools
and utilities and building a strong search engine. He
described the warehouse they have implemented to store data
using technology developed in-house called SKELEGEN. This
system deals with gigabytes of chemoinformatics screening
data generated by their research program. Currently it con-
tains more than 19,000 chemical structures and 60 projects
with nearly 100,000 data files each. 
Dave Parrish (Management Science Associates, Pittsburgh,
USA) discussed the issues involved in building a centralized
system for capturing laboratory information and presented a
well thought-out data-integration process. He described a
prototype system for flow cytometry data. In this example, the
data system begins with the development of the protocol and
establishing common data structures and dictionaries. The
model is ontology based and integration is accomplished using
an object-oriented (OO) approach, and collected data are sub-
jected to normalization and transformation before they are
put in the database. An object-oriented database is a gener-
2 Genome Biology Vol 3 No 8  Venkatesh and Harlowalization of a relational database that allows entries to be
abstract objects or collections of objects and successive spe-
cialization of these objects. For example, an ‘object’ might be
an abstract gene, and a specialization of a gene might be the
gene encoding a specific enzyme such as a protein kinase.
Objects can be thought of as collections of information,
where the information may include data itself and/or scripts
to display the data (protein structures, images, network
maps, or even other objects). Using the gene example, a gene
object might contain information on sequence, alleles,
protein structure, and source organism along with scripts to
display these data. Object-oriented databases give the scien-
tist substantial latitude to store the diverse types of data that
are encountered in the real world. 
Parrish also described Protégé-2000, an OO frame-based
system in which he and his colleagues have modeled domain
ontology (concepts and relationships) and method ontology
(for example, clinical guidelines and protocols) and created a
domain knowledge base that contains known facts. The
ontology they have developed extends beyond syntactic
properties (such as would be found in a data dictionary) to
include semantic characteristics (the hierarchical and
process relationships between objects and the meaning of
each entity). Data and procedures were packed into a
common structure, and building blocks (classes, slots and
facets) were used in an object-oriented approach. Parrish’s
example is a frame-based central repository, which appeared
to be able to handle object relationships, generally the
hardest task in data integration. 
David Hansen (Lion Biosciences, Heidelberg, Germany) dis-
cussed integrating extensible markup language (XML) data
with the sequence retrieval system (SRS) and relational
databases. XML is the web language for data interchange.
XML data is structured and is provided with a description
and the rules for data structure are stored in a document
called the document type declaration (DTD). SRS stores
sequence data in a text-file indexing system which allows the
data to be queried by field. It uses powerful web-based tools
for interrogating databases and abstracting information.
Application of XML using a meta-data approach is rapidly
becoming the method of choice for exchanging chemical and
biological data. Features of the meta-data approach to data
integration include its widespread use and its flexibility in
dealing with a variety of different data sources. XML,
coupled with appropriate meta-data, provides consistency
and transparency about the structure of data within an indi-
vidual data source, as well as a set of exchange standards.
DTDs are used to map XML data sources to SRS libraries,
using meta-data and metaphors to map XML object attrib-
utes with SRS fields and loading instructions or scripts. A
metaphor allows conditional indexing of one field to be
dependent on the content of another and contains micro-
syntax parsing rules to deal with data inconsistencies. To
integrate relational databases, Hansen and his colleagues
defined conceptual objects on top of the schema(s) and used
object-relation mapping for integration; this is essentially a
variation of database federation. By mapping XML data into
SRS concepts they have been able to overcome inconsisten-
cies in vocabularies and ontologies, map between XML data
standards, and integrate XML and non-XML data sources
into a common environment. Hansen presented an example
of an integrated database using an XML application in which
sequence information was tied to protein structure, to sig-
naling or metabolic pathway, and to function. 
The consensus of the conference was that there is no simple
solution to database integration. Federated databases using
three-layer architecture with web-based query tools were
popular because of their easy implementation. There was a
good deal of discussion on developing common ontologies.
Many of the participants felt that this approach might not
provide the optimal solution. Major challenges to developing
common ontologies were discussed, including difficulties in
capturing all information from biological systems because
our understanding of biological systems keeps changing,
and the disparate technical domains crossed by genomics
and bioinformatics. 
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